Antimicrobial potential of TiO2 nanoparticles against MDR Pseudomonas aeruginosa

Journal of Experimental Nanoscience

Volumn 10, Issue 11, 2015, Pages 819-827

  Arora, Bindu ^a   Murar, Madhura ^a   Dhumale, Vinayak ^b  

^a ABASAHEB GARWARE COLLEGE   (India)

^b DEFENCE INSTITUTE OF ADVANCED TECHNOLOGY   (India)

Author keywords

antimicrobial activity; multi drug resistant; Pseudomonas aeruginosa; TiO2 nanoparticle

Indexed keywords

ANTIBIOTICS; BACTERIA; METAL NANOPARTICLES; PHOSPHORUS COMPOUNDS; TIO2 NANOPARTICLES; TITANIUM DIOXIDE;

ANTI-MICROBIAL ACTIVITY; ANTI-MICROBIAL EFFECTS; DEGUSSA P25; MINIMUM INHIBITORY CONCENTRATION; MULTI-DRUG RESISTANT; NOSOCOMIAL PATHOGENS; PSEUDOMONAS AERUGINOSA; ULTRAVIOLET LIGHTS;

DRUG DELIVERY;

AMIKACIN; CEFACLOR; CEFADROXIL; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; NALIDIXIC ACID; NETILMICIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; TITANIUM DIOXIDE NANOPARTICLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; HOSPITAL INFECTION; LUNG LAVAGE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PUS; SPUTUM; TRACHEA; ULTRAVIOLET RADIATION;

EID: 84929284123     PISSN: 17458080     EISSN: 17458099     Source Type: Journal    
DOI: 10.1080/17458080.2014.902544     Document Type: Article

References (23)

1. Obritsch MD, Fish DN, MacLaren R, Jung R. Nosocomial infections due to multidrug-resistant pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy. 2005;25(10):1353–1364.
2. Mesaros N, Nordmann P, Ple´siat P, Roussel-Delvallez M, Van Eldere J, Glupczynski Y, Van Laethem Y, Jacobs F, Lebecque P, Malfroot A, Tulkens PM, Bambeke FV. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect. 2007;13:560–578.
3. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986 to April 1998. Am J Infect Control. 1998;26:522–533.
4. Finch R, Hunter PA. Antibiotic resistance–action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK. J Antimicrob Chemother. 2006;58:i3–i22.
5. Gottlieb T, Nimmo GR. Antibiotic resistance is an emerging threat to public health: an urgent call to action at the Antimicrobial Resistance Summit 2011. Med J Aust. 2011;194(6):281–283.
6. Falagas ME, Bliziotis IA. Pan drug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?. Int J Antimicrob Agents. 2007;29:630–636.
7. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium, Escherichia coli. Appl Environ Microbiol. 2007;73(6):1712–1720.
8. Fujishima A, Rao TN, Tryk DA. Titanium dioxide photocatalysis. J Photochem Photobiol C: Photochem Rev. 2000;1:1–2.
9. 2 based thin film. FEMS Microbiol Lett. 2002;211:183–188.
10. 2 reaction: toward an understanding of its killing mechanism. Appl Environ Microbiol. 1999;65(9):4094–4098.
11. Ravikumar S, Gokulakrishnan R, Selvanathan K, Selvam S. Antibacterial activity of metal oxide nanoparticles against ophthalmic pathogens. Int J Pharm Res Dev. 2011;3(5):122–127.
12. Stoimenov PK, Klinger RL, Marchin GL, Klabunde KJ. Metal oxide nanoparticles as bactericidal agents. Langmuir. 2002;18:6679–6686.
13. Fresta M, Puglisi G, Giammona G, Cavallaro G, Micali N, Furneri PM. Pefloxacine mesilate loaded and ofloxacin-loaded polyethylcyanoacrylate nanoparticles–characterization of the colloidal drug carrier formulation. J Pharm Sci. 1995;84:895–902.
14. Hamouda T, Hayes M, Cao Z, Tonda R, Johnson K, Craig W, Brisker J, Baker J. A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species. J Infect Dis. 1999;180:1939–1949.
15. Bauer AW, Kirby WM, Sherris JC, Turek M. Antibiotic susceptibility testing by standardized single disc method. Am J Clin Pathol. 1966;45:493–496.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. Villanova, PA: National Committee for Clinical Laboratory Standards; 2006 (9th ed.; Approved standard M2-A9).
17. Kikuchi Y, Sunada K, Iyoda T, Hashimoto K, Fujishima A. Photocatalytic bactericidal effect of TiO2 thin films: dynamic view of the active oxygen species responsible for the effect. J Photochem Photobiol A Chem. 1997;106:51–56.
18. Hoffman MR, Martin ST, Choi W, Behnemann DW. Environmental applications of semiconductor photocatalysis. Chem Rev. 1995;95:69–96.
19. 2 photocatalytic products. Environ Eng Res. 2008;13(3):136–140.
20. Blake DM, Maness PC, Huang Z, Wolfrum EJ, Huang J, Jacoby WA. Application of the photocatalytic chemistry of titanium dioxide to disinfection and the killing of cancer cells. Purif Methods. 1999;28:1–50.
21. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48(S1):5–16.
22. Furtado GL, Medeiros AA. Single-disk diffusion testing (Kirby–Bauer) of susceptibility of Proteus mirabilis to chloramphenicol: significance of the intermediate category. J Clin Microbiol. 1980;12(4);550–553.
23. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance. Clin Microbiol Rev. 2009;22(4);582–610.